A comparison of transcatheter aortic valve prosthesis platforms: Myval, Sapien, and Evolut in severe symptomatic aortic stenosis and low-moderate risk patients
The tri-match analysis of the real-world aortic stenosis patients with low to moderate surgical risk treated with the Myval, Sapien, and Evolut series showed comparable performance, safety, efficacy, and survival.
Authors
- Matjaž Bunc (ORCID: https://orcid.org/0000-0001-7269-8944)
- Polonca Kogoj
- Bojan Vrtovec (ORCID: https://orcid.org/0000-0002-7383-1281)
- Simon Terseglav
- Jana Ambrožič (ORCID: https://orcid.org/0000-0003-4864-7244)
- Ljupka Dimitrovska (ORCID: https://orcid.org/0000-0002-2467-5438)
- M Bervar (ORCID: https://orcid.org/0000-0002-1313-8928)
- Zlatko Fras (ORCID: https://orcid.org/0000-0003-0442-6175)
- Klemen Steblovnik (ORCID: https://orcid.org/0000-0003-2099-6389)
- Miha Čerček (ORCID: https://orcid.org/0000-0001-6193-0349)
- Miha Šušteršič (ORCID: https://orcid.org/0000-0003-0859-0837)
- Ana Kovač
- Patricija Pleskovic
Institutions
- University of Ljubljana (SI)
- Ljubljana University Medical Centre (SI)
- Institute of Oncology Ljubljana (SI)
Publication Details
- Journal
- Radiology and Oncology
- Published
- 2025-10-27
- DOI
- https://doi.org/10.2478/raon-2025-0046
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00